000 01206 a2200313 4500
005 20250514162206.0
264 0 _c20040308
008 200403s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.2003.01892.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLabiris, N R
245 0 0 _aPulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cDec 2003
300 _a588-99 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAbsorption
650 0 4 _aAdministration, Inhalation
650 0 4 _aAerosols
_xpharmacokinetics
650 0 4 _aBronchi
_xanatomy & histology
650 0 4 _aForced Expiratory Volume
_xphysiology
650 0 4 _aHumans
650 0 4 _aLung
_xphysiology
650 0 4 _aParticle Size
650 0 4 _aPharmaceutical Preparations
_xadministration & dosage
700 1 _aDolovich, M B
773 0 _tBritish journal of clinical pharmacology
_gvol. 56
_gno. 6
_gp. 588-99
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.2003.01892.x
_zAvailable from publisher's website
999 _c14353463
_d14353463